XML 65 R52.htm IDEA: XBRL DOCUMENT v3.19.1
Restatement of Consolidated Financial Statements, Consolidated Statement of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Jul. 31, 2018
Jul. 31, 2017
Jul. 31, 2016
Cash flows from operating activities [Abstract]      
Net income (loss) $ (104) $ 2,511 $ 154
Adjustments to reconcile net income to net cash provided by operating activities [Abstract]      
Impairment of long-lived assets 0 0 375
Depreciation and amortization 1,083 994 1,042
Provision for deferred income taxes 66 1,992 1,237
Share based compensation expense 127 69 28
Tax impact of share-based compensation 0 (6) 0
(Gain) loss on sale of assets and investment securities 17 (81) 135
Net recovery of contract adjustments (830) (1,178) (910)
Net bad debt expense (recovery) 1,034 164 453
Changes in [Abstract]      
- contract receivables 5,266 572 7,723
- other current assets 155 (178) (626)
- income tax receivable 353 134 (390)
- equity method investment (595) (158) (150)
- other non-current assets (822) (485) (5)
- accounts payable (2,023) 259 (2,789)
- accrued payroll costs 228 (110) (1,430)
- income taxes payable (44) (86) 38
- billings in excess of revenue 807 (78) 145
- other accrued liabilities (490) (43) 109
Net cash provided by operating activities 4,228 4,292 5,139
Cash flows from investing activities [Abstract]      
Purchase of property, building and equipment (772) (669) (692)
Proceeds from sale of subsidiaries 0 75 150
Proceeds from sale of building and equipment 43 1,495 5
Proceeds from maturity of investments 0 0 26
Purchase of investment securities (31) (30) (55)
Net cash (used in) provided by investing activities (787) 871 (566)
Cash flows from financing activities [Abstract]      
Dividends paid (1,721) (1,720) (2,066)
Proceeds from debt 0 200 6
Repayment of debt (389) (241) (547)
Net borrowings (repayment) of lines of credit (342) 39 (162)
Distributions to noncontrolling interests (454) (8) (345)
Net cash used in financing activities (2,906) (1,730) (3,114)
Effect of exchange rate changes on cash and cash equivalents 76 (228) (232)
Net increase in cash, cash equivalents and restricted cash 611 3,205 1,227
Cash, cash equivalents and restricted cash at beginning of period 13,135 9,930 8,703
Cash, cash equivalents and restricted cash at end of period 13,746 13,135 9,930
As Previously Reported [Member]      
Cash flows from operating activities [Abstract]      
Net income (loss)   2,953 608
Adjustments to reconcile net income to net cash provided by operating activities [Abstract]      
Impairment of long-lived assets     375
Depreciation and amortization   1,040 1,143
Provision for deferred income taxes   1,924 1,697
Share based compensation expense   69 37
Tax impact of share-based compensation   (6)  
(Gain) loss on sale of assets and investment securities   (81) 135
Net recovery of contract adjustments   (1,178) (910)
Net bad debt expense (recovery)   244 453
Changes in [Abstract]      
- contract receivables   (686) 7,394
- other current assets   (39) (400)
- income tax receivable   (376) (329)
- equity method investment   0 0
- other non-current assets   (14) 42
- accounts payable   1,160 (3,157)
- accrued payroll costs   (295) (1,909)
- income taxes payable   (89) 40
- billings in excess of revenue   (498) 607
- other accrued liabilities   269 (29)
Net cash provided by operating activities   4,397 5,797
Cash flows from investing activities [Abstract]      
Purchase of property, building and equipment   (721) (722)
Proceeds from sale of subsidiaries   75 150
Proceeds from sale of building and equipment   1,495 5
Proceeds from maturity of investments     26
Purchase of investment securities   (29) (55)
Net cash (used in) provided by investing activities   820 (596)
Cash flows from financing activities [Abstract]      
Dividends paid   (1,720) (2,066)
Proceeds from debt   200 6
Repayment of debt   (241) (547)
Net borrowings (repayment) of lines of credit   246 (380)
Distributions to noncontrolling interests   (680) (530)
Net cash used in financing activities   (2,195) (3,517)
Effect of exchange rate changes on cash and cash equivalents   160 (226)
Net increase in cash, cash equivalents and restricted cash   3,182 1,458
Cash, cash equivalents and restricted cash at beginning of period 13,343 10,161 8,703
Cash, cash equivalents and restricted cash at end of period   13,343 10,161
GAC Deconsolidation Adjustments [Member]      
Cash flows from operating activities [Abstract]      
Net income (loss)   (190) (252)
Adjustments to reconcile net income to net cash provided by operating activities [Abstract]      
Impairment of long-lived assets     0
Depreciation and amortization   (46) (31)
Provision for deferred income taxes   498 (434)
Share based compensation expense   0 0
Tax impact of share-based compensation   0  
(Gain) loss on sale of assets and investment securities   0 0
Net recovery of contract adjustments   0 0
Net bad debt expense (recovery)   (80) 0
Changes in [Abstract]      
- contract receivables   131 303
- other current assets   (168) 19
- income tax receivable   (503) 0
- equity method investment   (158) (150)
- other non-current assets   (471) (47)
- accounts payable   (185) 27
- accrued payroll costs   266 333
- income taxes payable   3 (62)
- billings in excess of revenue   420 (462)
- other accrued liabilities   (629) 110
Net cash provided by operating activities   (1,112) (646)
Cash flows from investing activities [Abstract]      
Purchase of property, building and equipment   52 30
Proceeds from sale of subsidiaries   0 0
Proceeds from sale of building and equipment   0 0
Proceeds from maturity of investments     0
Purchase of investment securities   (1) 0
Net cash (used in) provided by investing activities   51 30
Cash flows from financing activities [Abstract]      
Dividends paid   0 0
Proceeds from debt   0 0
Repayment of debt   0 0
Net borrowings (repayment) of lines of credit   (207) 218
Distributions to noncontrolling interests   672 185
Net cash used in financing activities   465 403
Effect of exchange rate changes on cash and cash equivalents   (30) (6)
Net increase in cash, cash equivalents and restricted cash   (626) (219)
Cash, cash equivalents and restricted cash at beginning of period (845) (219) 0
Cash, cash equivalents and restricted cash at end of period   (845) (219)
Out of Period Adjustments [Member]      
Cash flows from operating activities [Abstract]      
Net income (loss)   (252) (202)
Adjustments to reconcile net income to net cash provided by operating activities [Abstract]      
Impairment of long-lived assets     0
Depreciation and amortization   0 (70)
Provision for deferred income taxes   (430) (26)
Share based compensation expense   0 (9)
Tax impact of share-based compensation   0  
(Gain) loss on sale of assets and investment securities   0 0
Net recovery of contract adjustments   0 0
Net bad debt expense (recovery)   0 0
Changes in [Abstract]      
- contract receivables   1,127 26
- other current assets   29 (245)
- income tax receivable   1,013 (61)
- equity method investment   0 0
- other non-current assets   0 0
- accounts payable   (716) 341
- accrued payroll costs   (81) 146
- income taxes payable   0 60
- billings in excess of revenue   0 0
- other accrued liabilities   317 28
Net cash provided by operating activities   1,007 (12)
Cash flows from investing activities [Abstract]      
Purchase of property, building and equipment   0 0
Proceeds from sale of subsidiaries   0 0
Proceeds from sale of building and equipment   0 0
Proceeds from maturity of investments     0
Purchase of investment securities   0 0
Net cash (used in) provided by investing activities   0 0
Cash flows from financing activities [Abstract]      
Dividends paid   0 0
Proceeds from debt   0 0
Repayment of debt   0 0
Net borrowings (repayment) of lines of credit   0 0
Distributions to noncontrolling interests   0 0
Net cash used in financing activities   0 0
Effect of exchange rate changes on cash and cash equivalents   (357) 0
Net increase in cash, cash equivalents and restricted cash   650 (12)
Cash, cash equivalents and restricted cash at beginning of period $ 638 (12) 0
Cash, cash equivalents and restricted cash at end of period   $ 638 $ (12)